{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:25:37Z","timestamp":1791588337635,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007854","name":"School of Dentistry, Nihon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014420","name":"Dental Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007683","name":"Nihon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dental Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jds.2022.03.014","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T21:28:04Z","timestamp":1649885284000},"page":"1619-1625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study"],"prefix":"10.1016","volume":"17","author":[{"given":"Keisuke","family":"Seki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayoshi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kamimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Furuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jds.2022.03.014_bib1","first-page":"569","article-title":"NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7\u201329, 2000. Highlights of the conference","volume":"94","year":"2001","journal-title":"South Med J"},{"key":"10.1016\/j.jds.2022.03.014_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/BOR.0b013e32832cbc2a","article-title":"Future therapeutic targets in osteoporosis","volume":"21","author":"Deal","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jds.2022.03.014_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jds.2022.03.014_bib4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw \u2013 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.03.014_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jds.2022.03.014_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledoronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.03.014_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00774-017-0816-9","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw","volume":"35","author":"Yoneda","year":"2017","journal-title":"J Bone Miner Metabol"},{"key":"10.1016\/j.jds.2022.03.014_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"International task force on osteonecrosis of the jaw. Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jds.2022.03.014_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jds.2022.03.014_bib10","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00198-021-06078-z","article-title":"Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis","volume":"32","author":"Dos Santos Ferreira","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jds.2022.03.014_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jds.2021.07.014","article-title":"Peri-implantitis-induced medication-related osteonecrosis of the jaw: a case report","volume":"17","author":"Seki","year":"2022","journal-title":"J Dent Sci"},{"key":"10.1016\/j.jds.2022.03.014_bib12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/EDE.0b013e3181571e16","article-title":"Suggestions for STROBE recommendations","volume":"18","author":"Kuller","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.jds.2022.03.014_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jds.2022.03.014_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.jds.2022.03.014_bib15","first-page":"97","article-title":"The relationship between the chemistry and biological activity of the bisphosphonates","volume":"25","author":"Ebetino","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.jds.2022.03.014_bib16","series-title":"Ministry of internal affairs and communications. Statistical handbook of Japan 2020","author":"Statistics Bureau of Japan","year":"2020"},{"key":"10.1016\/j.jds.2022.03.014_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bjoms.2015.10.036","article-title":"Epidemiological study of alendronate-related osteonecrosis of the jaw in the southeast of Scotland","volume":"54","author":"Sammut","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.03.014_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.03.014_bib19","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.03.014_bib20","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/jc.2013-4119","article-title":"The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene","volume":"99","author":"Chiu","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jds.2022.03.014_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN","volume":"90","author":"Barasch","year":"2011","journal-title":"J Dent Res"},{"key":"10.1016\/j.jds.2022.03.014_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jds.2022.03.014_bib23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jds.2022.03.014_bib24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jds.2022.03.014_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdsr.2018.11.003","article-title":"Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan","volume":"55","author":"Shibahara","year":"2019","journal-title":"Jpn Dent Sci Rev"},{"key":"10.1016\/j.jds.2022.03.014_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00198-010-1274-6","article-title":"Oral bisphosphonate compliance and persistence: a matter of choice?","volume":"22","author":"Silverman","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jds.2022.03.014_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12891-017-1514-4","article-title":"Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis","volume":"18","author":"Park","year":"2017","journal-title":"BMC Muscoskel Disord"},{"key":"10.1016\/j.jds.2022.03.014_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00223-015-0045-y","article-title":"Impact of osteonecrosis of the jaw on osteoporosis treatment in Japan: results of a questionnaire-based survey by the Adequate Treatment of Osteoporosis (A-TOP) Research Group","volume":"97","author":"Taguchi","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jds.2022.03.014_bib29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1185\/03007995.2016.1170005","article-title":"Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw","volume":"32","author":"Taguchi","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jds.2022.03.014_bib30","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","article-title":"Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday","volume":"19","author":"Curtis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jds.2022.03.014_bib31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs","volume":"142","author":"Hellstein","year":"2011","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jds.2022.03.014_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development?","volume":"43","author":"Otto","year":"2015","journal-title":"J Cranio-Maxillo-Fac Surg"}],"container-title":["Journal of Dental Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1991790222000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1991790222000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T02:38:59Z","timestamp":1746844739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1991790222000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1991790222000629"],"URL":"https:\/\/doi.org\/10.1016\/j.jds.2022.03.014","relation":{},"ISSN":["1991-7902"],"issn-type":[{"value":"1991-7902","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Dental Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jds.2022.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}